Activation of cannabinoid receptor CB2 regulates LPS-induced pro-inflammatory cytokine production and osteoclastogenic gene expression in human periodontal ligament cells

Hong Qian, Jun Yi, Jingshi Zhou, Ya Zhao, Yongming Li, Zuolin Jin, Yin Ding

Department of General Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China.
Department of Hepatopancreatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China.
Department of Medical Microbiology and Parasitology, Fourth Military Medical University, Xi’an, China.
Department of Orthodontics, School of Stomatology, Fourth Military Medical University, Xi’an, China.

DOI: 10.4236/ojst.2013.31009                

Abstract

Background and Objective: It has been found that human periodontal ligament (hPDL) cells express cannabinoid receptor CB2. However, the functional importance of CB2 in hPDL cells exposed to bacterial endotoxins is not known. Here we investigate if the inflammation promoter lipopolysaccharide (LPS) affects CB2 expression and if activation of CB2 regulates LPS-induced pro-inflammatory cytokine production and osteoclastogenic gene expression in hPDL cells. Methods: The hPDL cells were obtained from extracted teeth of periodontally healthy subjects. CB2 expression in hPDL cells exposed to LPS was deter- mined by quantitative real-time PCR analysis. Then, the cells were incubated with or without CB2-specific agonist HU-308 before further stimulation with LPS. In some experiments, the cells were pre-treated with CB2-specific antagonist SR144528. The production of pro-inflammatory cytokines interleukin-1 beta (IL- 1β), interleukin-6 (IL-6) and tumor necrosis factoralpha (TNF-α) was assessed by enzyme-linked immunosorbent assay (ELISA). The mRNA expression of osteoclastogenic genes osteoprotegerin (OPG) and receptor activator of NF-κB ligand (RANKL) was examined using quantitative real-time PCR analysis. Results: CB2 expression in hPDL cells was markedly enhanced by LPS. HU-308 significantly suppressed the production of IL-1β, IL-6 and TNF-α exposed to LPS, whereas SR144528 attenuated this effect. The OPG/RANKL ratio decreased when exposed to LPS, furthermore increased significantly with the addition of HU-308 and finally decreased markedly after pretreatment with SR144528. Conclusion: Our study demonstrated that activation of CB2 had anti-inflammatory and anti-resorptive effects on LPS-stimulated hPDL cells. These findings suggest that activation of CB2 might be an effective therapeutic strategy for the treatment of inflammation and alveolar bone resorption in periodontitis.

Keywords

Cannabinoid Receptor CB2; Lipopolysaccharide; Human Periodontal Ligament Cells; IL-1β; IL-6; TNF-α; OPG; RANKL

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Agarwal, S., Baran, C., Piesco, N.P., et al. (1995) Synthesis of proinflammatory cytokines by human gingival fibroblasts in response to lipopolysaccha rides and interleukin-1 beta. Journal of Periodontal Research, 30, 382- 389. doi:10.1111/j.1600-0765.1995.tb01291.x
[2]	Lekic, P. and McCulloch, C.A. (1996) Periodontal ligament cell population: The central role of fibroblasts in creating a unique tissue. Anatomical Record, 245, 327- 341. doi:10.1002/(SICI)1097-0185(199606)245:2<327::AID-AR15>3.3.CO;2-6
[3]	Hou, L.T. and Yaeger, J.A. (1993) Cloning and characterization of human gingival and periodontal ligament fibroblasts. Journal of Periodontology, 64, 1209-1218. doi:10.1902/jop.1993.64.12.1209
[4]	Wada, N., Maeda, H., Tanabe, K., et al. (2001) Periodontal ligament cells secrete the factor that inhibits osteoclastic differentiation and function: The factor is osteoprotegerin/osteoclastogenesis inhibitory factor. Journal of Periodontal Research, 36, 56-63. doi:10.1034/j.1600-0765.2001.00604.x
[5]	Kanzaki, H., Chiba, M., Shimizu, Y., et al. (2001) Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition. Journal of Dental Research, 80, 887-891. doi:10.1177/00220345010800030801
[6]	Simonet, W.S., Lacey, D.L., Dunstan, C.R., et al. (1997) Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell, 89, 309-319. doi:10.1016/S0092-8674(00)80209-3
[7]	Yasuda, H., Shima, N., Nakagawa, N., et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Science of the United States of America, 95, 3597-3602. doi:10.1073/pnas.95.7.3597
[8]	Lacey, D.L., Timms, E., Tan, H.L., et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 93, 165-176. doi:10.1016/S0092-8674(00)81569-X
[9]	Yasuda, H., Shima, N., Nakagawa, N., et al. (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/ OCIF inhibits osteoclastogenesis in vitro. Endocrinology, 139, 1329-1337. doi:10.1210/en.139.3.1329
[10]	Squitieri, F., Cannella, M., Sgarbi, G., et al. (2006) Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation. Mechanisms of Ageing and Development, 127, 217-220. doi:10.1016/j.mad.2005.09.010
[11]	Klein, T.W., Newton, C., Larsen, K., et al. (2003) The cannabinoid system and immune modulation. Journal of Leukocyte Biology, 74, 486-496. doi:10.1189/jlb.0303101
[12]	Klein, T.W., Friedman, H. and Specter, S. (1998) Marijuana, immunity and infection. Journal of Neuroimmunology, 83, 102-115. doi:10.1016/S0165-5728(97)00226-9
[13]	Klein, T.W. (2005) Cannabinoid-based drugs as anti- inflammatory therapeutics. Nature Reviews Immunology, 5, 400-401. doi:10.1038/nri1602
[14]	Cabral, G.A. and Griffin-Thomas, L. (2009) Emerging role of the cannabinoid receptor CB2 in immune regulation: Therapeutic prospects for neuroinflammation. Expert Reviews in Molecular Medicine, 11, e3. doi:10.1017/S1462399409000957
[15]	Bab, I. (2005) The skeleton: Stone bones and stoned heads? In: Mechoulam, R., Ed., Cannabinoids as Therapeutics. Milestones in Drug Therapy Series. Birkh?user, Basel, 201-206. doi:10.1007/3-7643-7358-X_11
[16]	Ofek, O., Karsak, M., Leclerc, N., et al. (2006) Peripheral cannabinoid receptor, CB2, regulates bone mass. Proceedings of the National Academy of Science of the United States of America, 103, 696-701. doi:10.1073/pnas.0504187103
[17]	Scutt, A. and Williamson, E.M. (2007) Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. Calcified Tissue International, 80, 50-59. doi:10.1007/s00223-006-0171-7
[18]	Qian, H., Zhao, Y., Peng, Y., et al. (2010) Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells. Journal of Periodontal Research, 45, 504- 511.
[19]	Giannopoulou, C. and Cimasoni, G. (1996) Functional characteristics of gingival and periodontal ligament fibroblasts. Journal of Dental Research, 75, 895-902. doi:10.1177/00220345960750030601
[20]	Ivanovski, S., Li, H., Haase, H.R., et al. (2001) Expression of bone associated macromolecules by gingival and periodontal ligament fibroblasts. Journal of Periodontal Research, 36, 131-141. doi:10.1034/j.1600-0765.2001.360301.x
[21]	Somerman, M.J., Archer, S.Y., Imm, G.R., et al. (1988) A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. Journal of Dental Research, 67, 66-70. doi:10.1177/00220345880670011301
[22]	Almasri, A., Wisithphrom, K., Windsor, L.J., et al. (2007) Nicotine and lipopolysaccharide affect cytokine expression from gingival fibroblasts. Journal of Periodontology, 78, 533-541. doi:10.1902/jop.2007.060296
[23]	J?nsson, D., Nebel, D., Bratthall, G., et al. (2008) LPS- induced MCP-1 and IL-6 production is not reversed by oestrogen in human periodontal ligament cells. Archives of Oral Bi-ology, 53, 896-902. doi:10.1016/j.archoralbio.2008.05.001
[24]	Palmqvist, P., Lundberg, P., Lundgren, I., et al. (2008) IL-1beta and TNF-alpha regulate IL-6-type cytokines in gingival fibroblasts. Journal of Dental Research, 87, 558- 563. doi:10.1177/154405910808700614
[25]	Nakajima, Y., Furuichi, Y., Biswas, K.K., et al. (2006) Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. FEBS Letters, 580, 613-619. doi:10.1016/j.febslet.2006.02.046
[26]	Kozono, S., Matsuyama, T., Biwasa, K.K., et al. (2010) Involvement of the endocannabinoid system in periodontal healing. Biochemical and Biophysical Research Communications, 394, 928-933. doi:10.1016/j.bbrc.2010.03.080
[27]	Hanus, L., Breuer, A., Tchilibon, S., et al. (1999) HU-308: A specific agonist for CB (2), a peripheral cannabinoid receptor. Proceedings of the National Academy of Science of the United States of America, 96, 14228-14233. doi:10.1073/pnas.96.25.14228
[28]	Rizzo, A., Paolillo, R., Guida, L., et al. (2010) Effect of metronidazole and modulation of cytokine production on human periodontal ligament cells. International Immunopharmacology, 10, 744-750. doi:10.1016/j.intimp.2010.04.004
[29]	Jeong, G.S., Lee, S.H., Jeong, S.N., et al. (2009) Anti-inflammatory effects of apigenin on nicotine- and lipopolysaccharide-stimulated human periodontal ligament cells via heme oxygenase-1. International Immunopharmacology, 9, 1374-1380. doi:10.1016/j.intimp.2009.08.015
[30]	Chiang, C.Y., Kyritsis, G., Graves, D.T., et al. (1999) Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infection and Immunity, 67, 4231-4236.
[31]	Gemmell, E., Marshall, R.I. and Seymour, G.J. (1997) Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontology, 14, 112-143. doi:10.1111/j.1600-0757.1997.tb00194.x
[32]	Gamonal, J., Acevedo, A., Bascones, A., et al. (2000) Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. Journal of Periodontology, 71, 1535-1545. doi:10.1902/jop.2000.71.10.1535
[33]	Roberts, F.A., Hockett Jr., R.D, Bucy, R.P., et al. (1997) Quantitative assessment of inflammatory cytokine gene expression in chronic adult periodontitis. Oral Microbiology and Immunology, 12, 336-344. doi:10.1111/j.1399-302X.1997.tb00735.x
[34]	Holt, S.C., Kesavalu, L., Walker, S., et al. (1999) Virulence factors of Porphyromonas gingivalis. Periodontology, 20, 168-238. doi:10.1111/j.1600-0757.1999.tb00162.x
[35]	Napimoga, M.H., Benatti, B.B., Lima, F.O., et al. (2009) Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. International Immunopharmacology, 9, 216-222. doi:10.1016/j.intimp.2008.11.010
[36]	Ossola, C.A., Surkin, P.N., Pugnaloni, A., et al. (2012) Long-term treatment with methanandamide attenuates LPS-induced periodontitis in rats. Inflammation Research, 61, 941-948. doi:10.1007/s00011-012-0485-z
[37]	Hofbauer, L.C., Khosla, S., Dunstan, C.R., et al. (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. Journal of Bone and Min-eral Research, 15, 2-12. doi:10.1359/jbmr.2000.15.1.2
[38]	Crotti, T., Smith, M.D., Hirsch, R., et al. (2003) Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. Journal of Periodontal Research, 38, 380-387. doi:10.1034/j.1600-0765.2003.00615.x
[39]	Fukushima, H., Kajiya, H., Takada, K., et al. (2003) Expression and role of RANKL in periodontal ligament cells during physiological root-resorption in human deciduous teeth. European Journal of Oral Sciences, 11, 346-352. doi:10.1034/j.1600-0722.2003.00051.x
[40]	Liu, D., Xu, J.K., Figliomeni, L., et al. (2003) Expression of RANKL and OPG mRNA in periodontal disease: Possible involvement in bone destruction. International Journal of Molecular Medicine, 11, 17-21.
[41]	Han, X., Kawai, T. and Taubman, M.A. (2007) Interference with immune-cell-mediated bone resorption inperiodontal disease. Journal of Periodontology, 45, 76-94. doi:10.1111/j.1600-0757.2007.00215.x
[42]	Jin, Q., Ci-relli, J.A., Park, C.H., et al. (2007) RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. Journal of Periodontology, 78, 1300-1308. doi:10.1902/jop.2007.070073
[43]	Krajewski, A.C., Biessei, J., Kunze, M., et al. (2009) Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells. Acta Pathologica Microbiologica Scandinavica, 117, 746-754. doi:10.1111/j.1600-0463.2009.02532.x
[44]	Shu, L., Guan, S.M., Fu, S.M., et al. (2008) Estrogen modulates cytokine expression in human periodontal ligament cells. Journal of Dental Research, 87, 142-147. doi:10.1177/154405910808700214